Pharma majors Sanofi and GlaxoSmithKline (GSK) have reached an agreement with the UK government for supplying up to 60 million doses of their jointly developed COVID-19 vaccine candidate. The agreement will be subject to a final contract issued by the British government. The COVID-19 vaccine candidate has been developed by Sanofi in partnership with British […]
Significant Investment in Vaccine Production: French pharmaceutical giant Sanofi has announced plans to invest CAD 500 million (approximately $396.3 million) to construct a new vaccine manufacturing facility at its Canadian headquarters, Sanofi Pasteur, in Toronto. This development is aimed at bolstering the company’s operational capabilities in Canada and reaffirming its commitment to advancing global public […]
AstraZeneca’s MedImmune and Sanofi Pasteur have formed a research and development alliance for a new infant respiratory drug, MEDI8897 which they are planning to commercialize after getting through the clinical trials and the necessary regulatory approvals.
AstraZeneca’s biotech arm, MedImmune, and Sanofi Pasteur, the vaccines division of French pharmaceutical giant Sanofi, have entered into a significant research and development collaboration. The partnership, valued at approximately €615 million, aims to advance the development of MEDI8897, a monoclonal antibody for treating respiratory syncytial virus (RSV) infections in infants and children. Strategic Collaboration to […]
Sanofi Pasteur, the French pharmaceutical giant, has announced the rollout of Dengvaxia, the world’s first dengue vaccine, in Guatemala in the upcoming days. This significant development was revealed at a news conference in Guatemala City, marking a crucial step in the fight against dengue fever, a mosquito-borne viral infection that poses severe global health challenges. […]
Amgen Inc., a leading American biopharmaceutical company, has achieved a significant milestone with the approval of its drug Parsabiv (etelcalcetide) by the European Commission (EC) for the treatment of secondary hyperparathyroidism (sHPT) in adult patients undergoing hemodialysis due to chronic renal disease. Breakthrough in sHPT Management sHPT is a complex and chronic condition that affects […]